INFECTION

FDA warns four hand sanitizer companies on false claims

The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland
The U.S. Food and Drug Administration (FDA) said on Wednesday it issued four warning letters to companies that manufacture and market over-the-counter (OTC) drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA).
More news
IBTimes Logo

Cubist Pharma Shares Hit New High

Shares of Cubist Pharmaceuticals Inc. (CBST) touched a new 52-week high of $30.02 on Wednesday morning. Optimer Pharmaceuticals Inc. (OPTR) said it has entered an exclusive two-year co-promotion agreement with Cubist to market Dificid in the U.S.
IBTimes Logo

Cyber vulnerability in focus as targeted attacks poised to rise

Targeted attacks, including attacks on leading mobile platforms, are set to rise further in future, security software maker Symantec said on Tuesday. Targeted cyber attacks are more complex and challenging but the returns are also higher, prompting cyber criminal to launch more of this kind in future, a security strategist at Symantec told Reuters.

Pre-Market NASDAQ Movers (MSSR, VVUS, OREX, CIGX, OPTR, OVTI, DEPO, AMTD, LOGI, CHKP)

The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
Vertex Pharmaceuticals

Vertex Pharma Shares Hit New High Again

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) reported positive interim results on March 2 from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection. The shares of the drugmaker touched a new 52-week high of $51.10 on Friday.
Vertex Pharmaceuticals

Vertex Pharma stock hits new high again on positive study results

Shares of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) touched a new 52-week high of $50.83 on Thursday. The company announced positive interim results on Wednesday from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.
Vertex Pharmaceuticals

Vertex Pharma Stock Hits New High On Positive Hepatitis C-HIV Drug Study

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced positive interim results on Wednesday from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection. The shares of the drugmaker touched a new 52-week high of $47.82 on Wednesday.
IBTimes Logo

S.Africa customs shake-up to hit neighbours

The Southern Africa Customs Union (SACU) is considering a major overhaul of revenue-sharing that will see South Africa keeping a far bigger slice of pooled customs receipts, according to a policy document.
Nelson Mandela

Mandela recovering well, visitor rush a concern

Former South African President Nelson Mandela is recovering well from a respiratory infection that led to his hospitalisation last week but doctors are worried there may be too many people trying to visit him.

Years-old Conficker Worm Still A Threat

A computer worm that first appeared more than two years ago is still a threat, even though security experts were successful in mitigating possible damage.

Zsa Zsa Gabor to Sell Bel Air Mansion

Zsa Zsa Gabor and her husband Frederic Prinz von Anhalt are planning to sell their Bel Air, Calif., mansion for about $28 million. An option of lease and buy is also available, said John Blanchette, a publicist for Gabor.
IBTimes Logo

Debbi Morgan : I have Lyme disease

The Emmy award-winning actress Debbi Morgan, 54 year-old, hasconfessed that she is diagnosed with Lyme disease on a recent Tom Joyner Morning Show.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.